Erasca (ERAS) Enterprise Value (2020 - 2026)
Erasca (ERAS) reported Enterprise Value of -$243.8 million for Q1 2026, up 19.96% on a YoY basis from -$203.2 million in Q1 2025, and up 11.7% quarter-over-quarter from -$276.1 million in Q4 2025.
Erasca (ERAS) Enterprise Value (2020 - 2026) Analysis & Trends
Erasca has reported Enterprise Value for 7 years, with the latest figure at -$243.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 19.96% year-over-year to -$243.8 million; the trailing twelve-month figure through Mar 2026 stood at -$243.8 million (up 19.96% YoY), and the FY2025 full-year result was -$276.1 million, up 7.45% from the prior year.
- Enterprise Value for Q1 2026 stood at -$243.8 million, up from -$276.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$243.8 million in Q1 2026, with the low at -$435.6 million in Q4 2022.
- Historically, Enterprise Value has averaged -$330.9 million across 5 years, with a median of -$312.3 million in 2023.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 130.92% — and 2023, when it advanced 28.3%.
- Erasca's Enterprise Value stood at -$435.6 million in 2022, then grew by 28.3% to -$312.3 million in 2023, then advanced by 4.5% to -$298.3 million in 2024, then grew by 7.45% to -$276.1 million in 2025, then climbed by 11.7% to -$243.8 million in 2026.
- The last three Enterprise Value figures came in at -$243.8 million (Q1 2026), -$276.1 million (Q4 2025), and -$288.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - | -243.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -243.79 Mn |
| Dec 31, 2025 | -276.08 Mn |
| Sep 30, 2025 | -288.40 Mn |
| Jun 30, 2025 | -300.66 Mn |
| Mar 31, 2025 | -304.59 Mn |
| Dec 31, 2024 | -298.31 Mn |
| Sep 30, 2024 | -318.91 Mn |
| Jun 30, 2024 | -408.41 Mn |
| Mar 31, 2024 | -393.76 Mn |
| Dec 31, 2023 | -312.35 Mn |
| Sep 30, 2023 | -296.67 Mn |
| Jun 30, 2023 | -317.25 Mn |
| Mar 31, 2023 | -389.74 Mn |
| Dec 31, 2022 | -435.62 Mn |
| Sep 30, 2022 | -355.93 Mn |
| Jun 30, 2022 | -292.73 Mn |
| Mar 31, 2022 | -392.53 Mn |
| Dec 31, 2021 | -414.48 Mn |
| Sep 30, 2021 | -486.65 Mn |
| Jun 30, 2021 | -193.67 Mn |